Selected research
Market Structure
Global Isosorbide Mononitrate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Isosorbide Mononitrate market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Isosorbide Mononitrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Isosorbide Mononitrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Isosorbide Mononitrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Isosorbide Mononitrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Isosorbide Mononitrate include Teva, Shandong Fangming Pharmaceutical Group, Sandoz, ReYoung Pharmaceutical, Merck, Taj pharmaceutical, Nesher Pharmaceuticals, Intas Pharmaceuticals and Intas Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Isosorbide Mononitrate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Isosorbide Mononitrate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Isosorbide Mononitrate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Isosorbide Mononitrate market size, projected growth trends, production technologies, key applications, and end-use industries.
Isosorbide Mononitrate Segment by Company
Teva
Shandong Fangming Pharmaceutical Group
Sandoz
ReYoung Pharmaceutical
Merck
Taj pharmaceutical
Nesher Pharmaceuticals
Intas Pharmaceuticals
Intas Pharmaceuticals
Globus Remedies
AMRI
Isosorbide Mononitrate Segment by Type
10 mg Tablet
20 mg Tablet
Isosorbide Mononitrate Segment by Application
Treatment of Angina Pectoris
Others
Isosorbide Mononitrate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isosorbide Mononitrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Isosorbide Mononitrate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isosorbide Mononitrate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Isosorbide Mononitrate market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Isosorbide Mononitrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Isosorbide Mononitrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Isosorbide Mononitrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 10 mg Tablet
- 20 mg Tablet
Applications
- Treatment of Angina Pectoris
- Others
Companies covered
- Teva
- Shandong Fangming Pharmaceutical Group
- Sandoz
- ReYoung Pharmaceutical
- Merck
- Taj pharmaceutical
- Nesher Pharmaceuticals
- Intas Pharmaceuticals
- Intas Pharmaceuticals
- Globus Remedies
- AMRI
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Isosorbide Mononitrate Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Isosorbide Mononitrate Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Isosorbide Mononitrate Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Isosorbide Mononitrate Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Isosorbide Mononitrate Market Dynamics
- 2.1 Isosorbide Mononitrate Industry Trends
- 2.2 Isosorbide Mononitrate Industry Drivers
- 2.3 Isosorbide Mononitrate Industry Opportunities and Challenges
- 2.4 Isosorbide Mononitrate Industry Restraints
3 Isosorbide Mononitrate Market by Manufacturers
- 3.1 Global Isosorbide Mononitrate Revenue by Manufacturers (2021-2026)
- 3.2 Global Isosorbide Mononitrate Sales by Manufacturers (2021-2026)
- 3.3 Global Isosorbide Mononitrate Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Isosorbide Mononitrate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Isosorbide Mononitrate Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Isosorbide Mononitrate Manufacturers, Product Type & Application
- 3.7 Global Isosorbide Mononitrate Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Isosorbide Mononitrate Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Isosorbide Mononitrate Players Market Share by Revenue in 2025
- 3.8.3 2025 Isosorbide Mononitrate Tier 1, Tier 2, and Tier 3
4 Isosorbide Mononitrate Market by Type
- 4.1 Isosorbide Mononitrate Type Introduction
- 4.1.1 10 mg Tablet
- 4.1.2 20 mg Tablet
- 4.2 Global Isosorbide Mononitrate Sales by Type
- 4.2.1 Global Isosorbide Mononitrate Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Isosorbide Mononitrate Sales by Type (2021-2032)
- 4.2.3 Global Isosorbide Mononitrate Sales Market Share by Type (2021-2032)
- 4.3 Global Isosorbide Mononitrate Revenue by Type
- 4.3.1 Global Isosorbide Mononitrate Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Isosorbide Mononitrate Revenue by Type (2021-2032)
- 4.3.3 Global Isosorbide Mononitrate Revenue Market Share by Type (2021-2032)
5 Isosorbide Mononitrate Market by Application
- 5.1 Isosorbide Mononitrate Application Introduction
- 5.1.1 Treatment of Angina Pectoris
- 5.1.2 Others
- 5.2 Global Isosorbide Mononitrate Sales by Application
- 5.2.1 Global Isosorbide Mononitrate Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Isosorbide Mononitrate Sales by Application (2021-2032)
- 5.2.3 Global Isosorbide Mononitrate Sales Market Share by Application (2021-2032)
- 5.3 Global Isosorbide Mononitrate Revenue by Application
- 5.3.1 Global Isosorbide Mononitrate Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Isosorbide Mononitrate Revenue by Application (2021-2032)
- 5.3.3 Global Isosorbide Mononitrate Revenue Market Share by Application (2021-2032)
6 Global Isosorbide Mononitrate Sales by Region
- 6.1 Global Isosorbide Mononitrate Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Isosorbide Mononitrate Sales by Region (2021-2032)
- 6.2.1 Global Isosorbide Mononitrate Sales by Region (2021-2026)
- 6.2.2 Global Isosorbide Mononitrate Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Isosorbide Mononitrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Isosorbide Mononitrate Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Isosorbide Mononitrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Isosorbide Mononitrate Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Isosorbide Mononitrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Isosorbide Mononitrate Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Isosorbide Mononitrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Isosorbide Mononitrate Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Isosorbide Mononitrate Revenue by Region
- 7.1 Global Isosorbide Mononitrate Revenue by Region
- 7.1.1 Global Isosorbide Mononitrate Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Isosorbide Mononitrate Revenue by Region (2021-2026)
- 7.1.3 Global Isosorbide Mononitrate Revenue by Region (2027-2032)
- 7.1.4 Global Isosorbide Mononitrate Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Isosorbide Mononitrate Revenue (2021-2032)
- 7.2.2 North America Isosorbide Mononitrate Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Isosorbide Mononitrate Revenue (2021-2032)
- 7.3.2 Europe Isosorbide Mononitrate Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Isosorbide Mononitrate Revenue (2021-2032)
- 7.4.2 Asia-Pacific Isosorbide Mononitrate Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Isosorbide Mononitrate Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Isosorbide Mononitrate Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Teva
- 8.1.1 Teva Company Information
- 8.1.2 Teva Business Overview
- 8.1.3 Teva Isosorbide Mononitrate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Teva Isosorbide Mononitrate Product Portfolio
- 8.1.5 Teva Recent Developments
- 8.2 Shandong Fangming Pharmaceutical Group
- 8.2.1 Shandong Fangming Pharmaceutical Group Company Information
- 8.2.2 Shandong Fangming Pharmaceutical Group Business Overview
- 8.2.3 Shandong Fangming Pharmaceutical Group Isosorbide Mononitrate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Shandong Fangming Pharmaceutical Group Isosorbide Mononitrate Product Portfolio
- 8.2.5 Shandong Fangming Pharmaceutical Group Recent Developments
- 8.3 Sandoz
- 8.3.1 Sandoz Company Information
- 8.3.2 Sandoz Business Overview
- 8.3.3 Sandoz Isosorbide Mononitrate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Sandoz Isosorbide Mononitrate Product Portfolio
- 8.3.5 Sandoz Recent Developments
- 8.4 ReYoung Pharmaceutical
- 8.4.1 ReYoung Pharmaceutical Company Information
- 8.4.2 ReYoung Pharmaceutical Business Overview
- 8.4.3 ReYoung Pharmaceutical Isosorbide Mononitrate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 ReYoung Pharmaceutical Isosorbide Mononitrate Product Portfolio
- 8.4.5 ReYoung Pharmaceutical Recent Developments
- 8.5 Merck
- 8.5.1 Merck Company Information
- 8.5.2 Merck Business Overview
- 8.5.3 Merck Isosorbide Mononitrate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Merck Isosorbide Mononitrate Product Portfolio
- 8.5.5 Merck Recent Developments
- 8.6 Taj pharmaceutical
- 8.6.1 Taj pharmaceutical Company Information
- 8.6.2 Taj pharmaceutical Business Overview
- 8.6.3 Taj pharmaceutical Isosorbide Mononitrate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Taj pharmaceutical Isosorbide Mononitrate Product Portfolio
- 8.6.5 Taj pharmaceutical Recent Developments
- 8.7 Nesher Pharmaceuticals
- 8.7.1 Nesher Pharmaceuticals Company Information
- 8.7.2 Nesher Pharmaceuticals Business Overview
- 8.7.3 Nesher Pharmaceuticals Isosorbide Mononitrate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Nesher Pharmaceuticals Isosorbide Mononitrate Product Portfolio
- 8.7.5 Nesher Pharmaceuticals Recent Developments
- 8.8 Intas Pharmaceuticals
- 8.8.1 Intas Pharmaceuticals Company Information
- 8.8.2 Intas Pharmaceuticals Business Overview
- 8.8.3 Intas Pharmaceuticals Isosorbide Mononitrate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Intas Pharmaceuticals Isosorbide Mononitrate Product Portfolio
- 8.8.5 Intas Pharmaceuticals Recent Developments
- 8.9 Intas Pharmaceuticals
- 8.9.1 Intas Pharmaceuticals Company Information
- 8.9.2 Intas Pharmaceuticals Business Overview
- 8.9.3 Intas Pharmaceuticals Isosorbide Mononitrate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Intas Pharmaceuticals Isosorbide Mononitrate Product Portfolio
- 8.9.5 Intas Pharmaceuticals Recent Developments
- 8.10 Globus Remedies
- 8.10.1 Globus Remedies Company Information
- 8.10.2 Globus Remedies Business Overview
- 8.10.3 Globus Remedies Isosorbide Mononitrate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Globus Remedies Isosorbide Mononitrate Product Portfolio
- 8.10.5 Globus Remedies Recent Developments
- 8.11 AMRI
- 8.11.1 AMRI Company Information
- 8.11.2 AMRI Business Overview
- 8.11.3 AMRI Isosorbide Mononitrate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 AMRI Isosorbide Mononitrate Product Portfolio
- 8.11.5 AMRI Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Isosorbide Mononitrate Value Chain Analysis
- 9.1.1 Isosorbide Mononitrate Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Isosorbide Mononitrate Production Mode & Process
- 9.2 Isosorbide Mononitrate Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Isosorbide Mononitrate Distributors
- 9.2.3 Isosorbide Mononitrate Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst